Folakemi T. Odedina

Last updated

Folakemi Titilayo Odedina (born January 21, 1965) is a Nigerian-born scientist and professor of pharmacy and medicine at the University of Florida. [1] She is the principal investigator for the Prostate Cancer Transatlantic Consortium (CaPTC), [2] a clinical research group using genomic science and environmental etiology to exploring disproportionate burden of prostate cancer among Black men funded by the NCI. She is a member of American Cancer Society's National Prostate Cancer Disparities Advisory Team. [3]

Contents

Early years

Odedina was born on January 21, 1965, in Abeokuta, Ogun State, Nigeria to Ezekiel Shotayo Badejogbin and Grace Modupe Badejogbin. She spent her early childhood in Lagos and schooled at the Apostolic Church Primary School and Methodist Girls High School, Lagos. [4]

Education

Odedina obtained her Bachelor of Science in pharmacy at the Obafemi Awolowo University (OAU), Ile-Ife (formerly known as University of Ife) in 1986. She started a doctoral program in Pharmaceutical Sciences at the University of Florida in 1990 and earned her PhD in 1994. [5] Her thesis was titled "Implementation of Pharmaceutical Care in Community Practice: Development of a Theoretical Framework for Implementation". [6] [7]

Career

After earning her PhD, Odenina joined West Virginia University as an assistant professor. [5] She then served as professor of Medicine and Pharmacy at the Department of Radiation Oncology and the Department of Pharmacotherapy & Translational Research of the University of Florida before accepting a position as the Enterprise Deputy Director, Community Outreach and Engagement at the Mayo Clinic Comprehensive Cancer Center. [7]

She is also the Program Director of Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center- a National Cancer Institute funded U54 award. [8] Her scientific works focused on genetic, environmental determinants of prostate cancer disparity. [9] She also research on understanding the predictor of health disparities among Black men and exploration of behavioural interventions to improve the issues. She has led over 30 research projects prostate cancer disparities. [10] In 2006, she received the Fulbright Specialists Program to assess cancer data reporting system in Nigeria. She conducted the first national cancer research project on cancer data reporting system in Nigeria and was one of the leading authors of the Nigeria's first National Cancer Control Plan (NCCP). [11]

Odedina has mentored over 300 African scientists. She is the Chair of the Research Committee for the African Organisation for Research and Training in Cancer (AORTIC). [12] In 2017, she was awarded Carnegie African Diaspora Fellowship to work on prostate cancer risk and the development of oncology clinical trial virtual platforms at the University of Cape Town. [13] [14]

In an interview with SciDev in 2020, Odedina said that she experienced gender discrimination, when a female professor told her that she would not be able to finish her graduate programme because of marriage and pregnancy during her graduate school. [15]

She is the principal investigator of Prostate Cancer Transatlantic Consortium (CaPTC), a United States National Institute of Health/National Cancer Institute funded consortium that has over 50 institution members and research sites in Africa, Europe, North America and the Caribbean. [16]

Awards and honors

Related Research Articles

<span class="mw-page-title-main">Pharmacist</span> Healthcare professional

A pharmacist, also known as a chemist in Commonwealth English, is a healthcare professional who is knowledgeable about preparation, mechanism of action, clinical usage and legislation of medications in order to dispense them safely to the public and to provide consultancy services. A pharmacist also often serves as a primary care provider in the community and offers services, such as health screenings and immunizations.

A Doctor of Pharmacy is a professional doctorate in pharmacy. In some countries, it is a proficient graduate degree to practice the profession of pharmacy or to become a clinical pharmacist. In many countries, people with their Doctor of Pharmacy are allowed to practice independently and can prescribe drugs directly to patients. A PharmD program has significant experiential and/or clinical education components in introductory and advanced levels for the safe and effective use of drugs. Experiential education prepares graduates to be practice-ready, as they already have spent a significant amount of time training in areas of direct patient care and research.

Graham Andrew Colditz MD, DrPH is an Australian chronic disease epidemiologist. He is the inaugural Niess-Gain Professor at Washington University School of Medicine, where he is associate director for Prevention and Control at the Alvin J. Siteman Cancer Center. He directs the Master of Population Health Science at Washington University School of Medicine. During medical training he was excited by the potential for prevention of chronic diseases. With encouragement from mentors he pursued training in the US as it was routine for academics in Australia to obtain overseas training at that time. He is internationally recognized for leadership in cancer prevention, and is often interviewed by media for input on this topic. With members of Cancer Prevention and Control at Siteman, he blogs on issues relating to cancer prevention and screening. According to Google Scholar statistics, Colditz has a h-index of more than 300. Colditz was a member of the Institute of Medicine Committee to Review Adverse Effects of Vaccines but resigned, along with Ruby H. N. Nguyen, before it produced its seminal report.

Krisana Kraisintu is a Thai professor and pharmacist, as known as the "Gypsy pharmacist". She was pharmaceutical consultant in the local production and increased access to life-saving medicines in Africa, in particular, malaria and HIV/AIDS-related drug production.

<span class="mw-page-title-main">Charles Sawyers</span> American physician-scientist (born 1959)

Charles L. Sawyers is a Howard Hughes Medical Institute (HHMI) investigator who holds the Marie-Josée and Henry R. Kravis Chair of the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center (MSK). HOPP is a program created in 2006 that comprises researchers from many disciplines to bridge clinical and laboratory discoveries.

UIC College of Pharmacy at the University of Illinois Chicago is one of the oldest pharmacy schools in the US, and oldest unit of the University of Illinois system.

<span class="mw-page-title-main">Olufunmilayo Olopade</span> Nigerian physician

Olufunmilayo I. Olopade born in the year 1957, is a Nigerian hematology oncologist, Associate Dean for Global Health and Walter L. Palmer, Distinguished Service Professor in Medicine and Human Genetics at the University of Chicago. She also serves as director of the University of Chicago Hospital's Cancer Risk Clinic.

Otis Webb Brawley is an American physician and the Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University. He served as Chief Medical and Scientific Officer and Executive Vice President of the American Cancer Society from July 2007 to November 2018. He is board certified in internal medicine and medical oncology and is a Master of the American College of Physicians, Fellow of the American Society of Clinical Oncology, and a Fellow of the American College of Epidemiology. He is a member of the Institute of Medicine now known as the National Academy of Medicine.

William Douglas Figg is an American scientist (pharmacologist). He is a senior investigator (tenured) at the National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland. He holds multiple titles within the NCI: Associate Director of the Center for Cancer Research, Co-Director of the Office of Translational Resources, Acting Branch Chief for the Genitourinary Malignancies Branch, Chief of the Clinical Pharmacology Program, and head of the Molecular Pharmacology Section. Figg is also the Co-chief of Basic Research at the Center for Prostate Disease Research within the Walter Reed National Military Medical Center – Murtha Cancer Center in Bethesda, Maryland.

<span class="mw-page-title-main">Ahmed Tijjani Mora</span> Nigerian pharmacist and academic

Ahmed Tijjani Mora (OON) is a Nigerian pharmacist, academic, former Registrar and now Chairman of the Governing Council of Pharmacy Council of Nigeria. He is the National President, Ahmadu Bello University Alumni Association. He was elected President of the Alumni Association in August 2015 at the Annual General Assembly (AGA) of the association. The assembly was attended by delegates from over 25 States. Prior to his election, he was the substantive Deputy National president of the association.

Professor Carol L. Prives FRS is the Da Costa Professor of Biological Sciences at Columbia University. She is known for her work in the characterisation of p53, an important tumor suppressor protein frequently mutated in cancer.

Mojisola Christianah Adeyeye is a Nigerian pharmacist and professor. She was appointed the Director-General of National Agency for Food and Drug Administration and Control (NAFDAC) on 3 November 2017 by the President of The Federal Republic of Nigeria, Muhammadu Buhari. Before her appointment as NAFDAC boss, she was the founding Chair of Biopharmaceutical Sciences and a Professor of Pharmaceutics, Manufacturing Science and Drug Product Evaluation at the College of Pharmacy, Roosevelt University in Schaumburg, Illinois, where she spent 7 years. She was also a Professor of Pharmaceutics and Manufacturing for 21 years at Duquesne University in Pittsburgh, Pennsylvania, USA. She is Senior Fulbright Scholar and Specialist and 2008 American Association of Pharmaceutical Scientists Fellow. She is also a Fellow of the Nigerian Academy of Science and Nigeria Academy of Pharmacy. Her research interests are in the areas of pre-formulation, early phase development of solid, semisolid and liquid dosage forms, and IND-based and intellectual property-driven late phase drug product development. She is the founder and President of Elim Pediatric Pharmaceuticals Rolling Meadows, Illinois. Through Duquesne University, she was able to develop an anti-retroviral (HIV/AIDS) pediatric fixed-dose combination and received intellectual property on the formulations in the UK and South Africa.

Dafna Bar-Sagi is a cell biologist and cancer researcher at New York University School of Medicine. She is the Saul J. Farber Professor in the department of biochemistry and molecular pharmacology and the department of medicine and senior vice president and vice dean for science at NYU Langone Health. Bar-Sagi has been a member of scientific advisory boards, including the National Cancer Institute, Starr Cancer Consortium, and Pancreatic Cancer Action Network.

<span class="mw-page-title-main">Lucile Adams-Campbell</span> American epidemiologist

Lucile L. Adams-Campbell is the first African-American woman to receive a PhD in epidemiology in the United States. She serves as the Professor of Oncology at Lombardi Comprehensive Cancer Center and associate director for Minority Health at the Georgetown University Medical Center. She is a Fellow of the National Academy of Medicine, and the Washington DC Hall of Fame.

<span class="mw-page-title-main">Julie A. Johnson</span> American clinical pharmacist

Julie Ann Johnson is an American clinical pharmacist and translational scientist. She currently serves as associate dean for clinical and translational research and holds the Dr. Samuel T. and Lois Felts Mercer Professorship of Medicine and Pharmacology at The Ohio State University College of Medicine. She is also associate vice president for research at Ohio State. Johnson comes to Ohio State from the University of Florida, where she was dean emeritus of pharmacy and a distinguished professor of pharmacy and medicine in the Department of Pharmacotherapy & Translational Research. For four consecutive years, she was a Clarivate Analytics Highly Cited Researcher in Pharmacology and Toxicology, indicating she was one of the "world's leading scholars in the sciences and social sciences in the preceding decade."

Karen E. Knudsen is Chief Executive Officer of American Cancer Society and its advocacy affiliate the American Cancer Society Cancer Action Network. She is the first woman to hold that position in either organization.

<span class="mw-page-title-main">Mary V. Relling</span> American pharmacogeneticist

Mary Violet Relling is an American pharmacogeneticist. Relling's research focuses on pharmacokinetics and pharmacodynamics in children and how genome variability influences a child's response to cancer chemotherapy.

Bushra Ateeq is a Professor and a Senior Fellow of the DBT/Wellcome Trust India Alliance in the Department of Biological Sciences and Bioengineering (BSBE), IIT Kanpur specializing in cancer biology and molecular oncology. She was awarded the Shanti Swarup Bhatnagar Prize for Science and Technology in Medical Sciences in the year 2020. Her research interest involves exploration of the genetic and epigenetic changes that initiate cancer and its progression. She is also focusing on understanding the molecular events that drive cancer and resistance towards chemotherapeutic drugs.

Carol L. Brown is the Nicholls-Biondi Chair for Health Equity at Memorial Sloan Kettering Cancer Center and a professor at Weill Cornell Medical College. She is a surgeon known for her work on gynecological cancers.

References

  1. ↑ "Folakemi Odedina". University of Florida. University of Florida Health Sciences Centre. Archived from the original on 25 January 2021. Retrieved 2 February 2021.
  2. ↑ Institute, National Cancer. "Prostate Cancer Transatlantic Consortium (CaPTC) | EGRP/DCCPS/NCI/NIH". epi.grants.cancer.gov. National Cancer Institute. Retrieved 2 February 2021.
  3. ↑ "Dr. Folakemi Odedina appointed to American Cancer Society and Nigerian University System research groups » College of Pharmacy » University of Florida". University of Florida Health Science Center. Retrieved 2 February 2021.
  4. ↑ Sokoya, Kemi (8 July 2017). "'Actionable research is key to defeating prostate cancer'". The Guardian Nigeria News - Nigeria and World News. Retrieved 2 February 2021.
  5. 1 2 Aboderin, Ola (2023-06-18). "Folakemi Odedina: Pharmacist-Oncologist Saving Men's Lives". Pharmanews. Retrieved 2024-08-06.
  6. ↑ "Ph.D. Alumni". Department of Pharmaceutical Outcomes & Policy -- College of Pharmacy -- University of Florida. 2020-01-01. Retrieved 2024-08-06.
  7. 1 2 "Folakemi T. Odedina, Ph.D." Mayo Clinic. 2021-10-13. Retrieved 2024-08-06.
  8. ↑ Health Equity Center, CaRE2. "CaRE2 Health Equity Center @ UF » UF Health Cancer Center » University of Florida". care2.cancer.ufl.edu. University of Florida Health Sciences. Archived from the original on 22 January 2021. Retrieved 2 February 2021.{{cite web}}: CS1 maint: numeric names: authors list (link)
  9. ↑ Washam, Cynthia (25 December 2010). "Cancer Disparities Not Simply Black and White". Oncology Times. 32 (24): 29–30. doi: 10.1097/01.COT.0000392903.18151.97 .
  10. ↑ NCI, National Cancer Institute. "Transatlantic Roots of Prostate Cancer Disparities in Black Men: The CaPTC Program". Cancer Prevention Fellowship Program. U.S. Department of Health and Human Services. Archived from the original on 18 March 2021. Retrieved 2 February 2021.
  11. ↑ IYBSSD, International Year Basic Sciences for Sustainable Development (16 October 2021). "Folakemi Odedina: "How I turned brain drain to brain gain"". International Year of Basic Sciences for Development. SciDev.Net. Retrieved 2 February 2021.
  12. ↑ AORTIC, African Organisation on Research and Training in Cancer. "Research Committee". AORTIC AFRICA. African Organisation on Research and Training in Cancer. Retrieved 2 February 2021.
  13. ↑ AACR, American Association for Cancer Research. "Folakemi T. Odedina, PhD | MICR Council | AACR". American Association for Cancer Research (AACR). Retrieved 2 February 2021.
  14. ↑ Post, The ASCO. "Folakemi Odedina Fellowship for Oncology Clinical Trials in Africa - The ASCO Post". ascopost.com. American Society of Clinical Oncology. Retrieved 2 February 2021.
  15. ↑ Royal, Uche (24 September 2020). "Q&A: How I turned brain drain to brain gain". Sub-Saharan Africa. SciDev. Retrieved 2 February 2021.
  16. ↑ Sokoya, Kemi (8 July 2017). "'Actionable research is key to defeating prostate cancer'". The Guardian Nigeria News - Nigeria and World News. Retrieved 2 February 2021.
  17. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 "Folakemi T. Odedina, Ph.D." Mayo Clinic. Retrieved 2024-08-07.
  18. 1 2 3 4 5 6 7 8 "Folakemi T. Odedina, PhD, Recognized with 2023 AACR Distinguished Lectureship on the Science of Cancer Health Disparities". American Association for Cancer Research (AACR). 2024-02-08. Retrieved 2024-08-07.
  19. 1 2 3 "Celebrating International Women's Month: Dr. Folakemi Odedina". www.crdfglobal.org. CRDF Global. Retrieved 2 February 2021.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.